None listed
Conditions
Interventions
Others : The intervention group is applied to use the ePRO-CTCAE mobile application at least once weekly with routine care until they visit the outpatient clinic after completing the last cycle of che
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) 20 years of age or older (if necessary due to the nature of the disease, people aged 70 or older may be included in this study with the consent of their caregivers according to the decision of the healthcare professionals) 2) diagnosed with breast, endometrial, colon, or lung cancer; planning to receive the first cycle of therapy (for both curative and palliative intent) or one year has been passed after the end of therapy (for curative intent only) 3) 0 or 1 in ECOG (Eastern Cooperative Oncology) performance status 4) capable to use a smartphone (Android OS only) and mobile applications 5) understanding the purpose of this study and expressing willingness to participate in this study
Exclusion criteria
Exclusion criteria: 1) judged by the researcher to be restricted from participating in this study 2) planned to receive concurrent chemoradiation therapy (CCRT) 3) determined by the researcher to be unable to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in physical function between those who receive the symptom management during chemotherapy through the ePRO-CTCAE mobile application and those who does not. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in physical activity between those who receive the symptom management during chemotherapy through the ePRO-CTCAE mobile application and those who does not.;Changes in pain interference score between those who receive the symptom management during chemotherapy through the ePRO-CTCAE mobile application and those who does not.;Changes in depressive symptom score between those who receive the symptom management during chemotherapy through the ePRO-CTCAE mobile application and those who does not.;Changes in health-related quality of life between those who receive the symptom management during chemotherapy through the ePRO-CTCAE mobile application and those who does not.;The completion rate of planned chemotherapy between those who receive the symptom management during chemotherapy through the ePRO-CTCAE mobile application and those who does not.;The rate of unplanned clinical visits between those who receive the symptom management during chemotherapy through the ePRO-CTCAE mobile application and those who does not.;Additional medical expenditure for symptom management between those who receive the symptom management during chemotherapy through the ePRO-CTCAE mobile application and those who does not.;Survival rate at 12 months after the end of chemotherapy between those who receive the symptom management during chemotherapy through the ePRO-CTCAE mobile application and those who does not. | — |
Countries
Korea, Republic of
Contacts
Public ContactMieun Kim
Samsung Medical Center
Outcome results
None listed